Clinical Trial Update: A Study of CM310 in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update indicating that CM310 for chronic obstructive pulmonary disease is in Phase 2 and Phase 3, with recruitment not yet started.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• CM310

Snippet

Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | Conditions: Chronic Obstructive Pulmonary Disease | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING